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Introduction
Laminin-211 (α2β1γ1 subunits, abbreviated herein as Lm211) is 
the major laminin of the basement membrane (BM) of skeletal 
muscle and peripheral nerve Schwann cells. Mutations with-
in the LAMA2 gene coding for laminin α2 (referred to herein 
as Lmα2) cause an estimated 30% of the cases of congenital 
muscular dystrophy (type MDC1A). These mutations usually 
result in a complete loss of protein subunit expression. The 
pathology consists of muscle degeneration and regeneration, 
chronic inflammation, and fibrosis that can be accompanied by 
reduced peripheral nerve conduction (1). Patients with muta-
tions resulting in absent or very low protein expression levels 
fail to ambulate and often die of muscle wasting and respirato-
ry failure by their second decade of life (1). Missense mutations 
clustered in the Lmα2 N-terminal (LN) globular domain α2LN, 
which probably adversely affect polymerization, also occur 
(2, 3, and reviewed in ref. 4). Human α2LN domain mutations 
with retained Lmα2 subunit expression include Y138H, Q167P, 
L243P, and G248R, which are located on a polymerization face 
identified in α2LN domain (4, 5). Patients with this type of 
mutation have little-to-modest reduced protein levels present, 
with a milder limb-girdle–type dystrophy, in which ambulation 
is achieved (3, 6, 7). There is currently no effective treatment 
for these dystrophies.
The sarcolemmal BM can be regarded as a layer of transversely 
linked extracellular matrix (matrix) proteins extending from stromal 
collagens to cell-surface receptors to cytoskeleton. This BM also con-
tains laterally interlinked proteins consisting of the laminin and col-
lagen IV polymer networks that stabilize the transverse linkages (8). 
Two major types of interaction anchor the BM to the muscle cytoskel-
eton. These interactions take place in a complex of dystroglycan (DG), 
dystrophin, and dystrophin-associated glycoproteins on the one hand, 
and integrin α7β1 and associated cytoplasmic adaptor proteins on 
the other (9–11). The BM ligands for α-dystroglycan (αDG) in skeletal 
muscle are the C-terminal LG globular domains of Lm211, agrin, and 
perlecan. Integrin α7β1 interacts with α2-laminins and, when present, 
α1- and α5-laminins (12). DG may provide the more critical link to the 
cytoskeleton in muscle (13), as a number of mutations found to alter 
the αDG mannosyl-O–linked carbohydrate critical for ligand binding 
cause severe congenital and limb-girdle dystrophies (1).
A model of BM assembly and structure, based on biochemi-
cal, cell, and genetic studies performed by us and others has pro-
vided a basis from which to interpret the BM changes that occur 
in laminin deficiency (14–16). In this model, assembly is initiated 
by laminins that bind to αDG, integrin, and sulfated glycolipids, 
the first two providing critical anchorage to the underlying cyto-
skeleton and the latter increasing the laminin-binding capacity 
of the cell surface. Nidogen attaches to laminin to form a stable 
bridge with collagen IV. The proteoglycans agrin and perlecan, 
the first binding to the laminin coiled-coil and the latter binding 
to the internally located nidogen globular G2 domain, bestow 
additional anchorage (collateral linkage) by binding to αDG. For 
Lm211 (like Lm111), the LG-ligating receptors are αDG and inte-
grin α7β1. The laminin then polymerizes through interactions 
of the 3 different short-arm LN domains to form a sheet-like 
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G2 predicted to bind to perlecan (30), thereby preserving all known 
BM assembly functions that might otherwise be lost by replacing 
nidogen with αLNNd. To test the model of laminin polymerization 
in vivo, αLNNd-encoding cDNA was transgenically expressed in 
mice under the control of the muscle creatine kinase (MCK) pro-
moter. αLNNd was detected as an approximately 157-kDa protein 
in muscle (Figure 1C) and was incorporated into sarcolemmal BM 
as seen by bright immunostaining in muscle (Figure 1D). 
Transgenic expression of αLNNd in dy2J mice. The αLNNd trans-
gene was bred into dy2J/+ mice (referred to herein as Tg+dy2J mice) 
for evaluation of the effect of αLNNd in homozygous mutant mice. 
In dy2J mice, a 57-residue-long part of an N-terminal segment with-
in the laminin α2LN domain is deleted as a consequence of a splice 
donor defect (27, 28). This deletion was found to destabilize the α2LN 
domain, such that it then readily degrades through proteolysis, mak-
ing the laminin unable to polymerize (25). If the laminin assembly 
model is correct, expression of αLNNd would be predicted to restore 
this polymerization deficit and ameliorate the muscular dystrophy.
Grip strength. Dystrophic mice showed signs of a hind limb 
gait abnormality by 3 weeks of age that was followed by weakness 
in all limbs. We evaluated this weakness by specific grip strength 
measurements (grams of peak force divided by mouse weight) as 
a function of age (Figure 2). At 3 weeks, we detected no signifi-
cant reduction of grip strength in the forelimbs of dystrophic mice, 
whereas small differences were detected in the hind limbs and 
combined fore- and hind limbs. By 4 weeks, we found that forelimb 
grip strength was reduced in dystrophic mice to half that of control 
mice. In the presence of the transgene, only a small reduction in 
forelimb grip strength was detected compared with controls. By 
6 weeks of age, dystrophic mouse grip strength had increased to 
approximately 60% of control levels, whereas Tg+dy2J mouse 
grip strength had increased to levels statistically indistinguishable 
from those of normal control mice. This set of relationships did 
not change through 11 weeks age. Although females weighed less 
than males in adulthood, no significant specific grip strength dif-
ferences were found between the sexes (Supplemental Figure 1; 
supplemental material available online with this article; https://
doi.org/10.1172/JCI90854DS1). Also, no differences were noted 
among the 4 control genotypes. In addition to the quantitative dif-
ferences, by 4 weeks of age, it was possible to distinguish between 
control and dy2J mice by simply pulling mice away from a wire 
mesh gripped with the forelimbs: dy2J mice were considerably 
weaker than were control mice, while control and Tg+dy2J mice 
had similar forelimb grip strength.
Hind limb grip strength measured in isolation was less than 
forelimb grip strength. As the mice aged between 3 and 11 weeks, 
dy2J hind limb grip strength was reduced from 2.5 to 3.5 gm/gm to 
1.5 to 2 gm/gm. αLNNd transgene expression partially improved 
grip strength through 7 weeks, but not thereafter. Loss of the trans-
gene benefit corresponded to the development of permanent hind 
limb extension contractures, which are the result of  prominent 
peripheral neuropathy, a phenotype that is not affected by expres-
sion of the transgene in skeletal muscle. When all limbs were eval-
uated together, the small initial reduction of grip strength in dy2J 
mice became maximal by 5 weeks of age, with transgene expres-
sion associated with an improvement in grip strength of approxi-
mately 50% compared with that of controls, reflecting full recov-
laminin network, linking the laminins and their receptor- and 
matrix-binding partners into a cohesive unit (5, 17–21).
Compositional and structural changes underlie the BM alter-
ations in Lmα2 deficiency. In one mouse model of severe loss of 
Lmα2 (dyW/dyW mice), the absence of Lm211 results in increased 
transcription and protein expression of Lm411, with a more limit-
ed increase in Lm511 (22). It has been deduced that the compensa-
tory Lm411 is unable to polymerize because it lacks an α-short arm 
with its critical LN domain (16). Furthermore, there is evidence 
from protein and protein fragment studies that the LG domains 
of Lm411 bind poorly to αDG and integrins (12, 23). While Lm511 
binds to several integrins and can polymerize, its LG domains 
have been reported to bind less well to integrin α7β1 and αDG (5, 
12, 24). Thus, one explanation for the severe muscular dystrophy 
seen in MDC1A patients is a failure of the muscle BM to properly 
assemble via the LN domains and to be linked to the muscle sarco-
lemma via the LG domains.
Homozygous dy2J/dy2J-mutant mice (abbreviated herein as 
dy2J mice) lack α2LN polymerization activity and serve as a mod-
el for the ambulatory type of Lmα2 deficiency that is thought to 
result from a failure of polymerization (25–28). The measured 
polymerization deficiency of a truncated Lm211 in vitro and 
the dy2J phenotype suggest a significant contribution of the LN 
domain–mediated laminin network to muscle fiber stability (25). 
These considerations have led us to evaluate the specifically 
designed protein called αLNNd, which possesses an α1 N-terminal 
LN polymerization domain and binds to the laminin γ1 chain  via 
a nidogen-binding site (15). To this end, we sought to test the 
laminin assembly model and the validity of the dy2J polymeriza-
tion deficit hypothesis and to explore a possible new therapeutic 
approach for muscular dystrophy. Initially engineered to provide 
a gain-of-function tool to probe laminin self-assembly, it was pre-
dicted that αLNNd would also provide the matrix-forming struc-
tural linkages lost in muscular dystrophy (Figure 1, A and B). In the 
current study, we report that αLNNd indeed repaired the skeletal 
muscle defects in dy2J mice and enabled the assembly of nonpo-
lymerizing laminins in a muscle BM in culture. These experiments 
provide a proof of concept for the development of a new treatment 
option for ambulatory-type MDC1A, while at the same time vali-
dating a mechanistic model of BM assembly with predictive value.
Results
Laminin and laminin-binding linker proteins. Previous work in vitro 
revealed that polymerization is mediated by the N-terminal lami-
nin α-, β-, and γ-subunit LN domains that bind to each other to 
form a ternary node (14, 17–19, 29). One study (15) described the 
biochemical and Schwann cell BM assembly characteristics of a 
recombinant 157-kDa chimeric protein, designated αLNNd. This 
engineered chimeric protein consists of the mouse N-terminal moi-
ety of the laminin α1-short arm (LN and 4 adjacent LEa domains) 
fused to the nidogen-1 N-terminal domains G2 through G3 (Fig-
ure 1A). The G3 domain of αLNNd binds to the nidogen-1–binding 
locus (LEb3) on the γ1-short arm of recombinant Lm111, adding an 
additional short arm. The α1LN domain on this arm can substitute 
for the native α2LN domain for polymerization when the α-short 
arm is absent (Figure 1B). The chimeric protein also binds to colla-
gen IV through the G2 and G3 domains of the nidogen moiety, with 
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Muscle forelimb histology and morphometry. H&E-stained dy2J 
muscles examined in cross sections of the extensor carpi radialis 
longus and brevis revealed characteristic dystrophic changes includ-
ing reduced overall cross-sectional size, small and variable myofiber 
size, increased presence of central nuclei, rounding of myofibers in 
cross sections, and weakly stained interstitial material separating 
myofibers (Figure 3). We detected histological abnormalities in dy2J 
forelimb muscle at 3 to 4 weeks of age. By 11 weeks, we observed a 
ery of forelimb grip strength in the absence of substantial hind limb 
improvement. The full degree of muscle transgene–dependent 
restoration of forelimb function demonstrates the importance of 
laminin polymerization. It also indicates that the peripheral neu-
ropathy contributes little to the dy2J loss of forelimb strength. The 
limited improvement in hind limb strength, on the other hand and 
as discussed ahead, likely reflects the significant contribution of 
dy2J sciatic nerve amyelination to hind limb function.
Figure 1. αLNNd transgene. (A) αLNNd is a chimeric 
protein consisting of murine Lmα1 LN-LEa domains fused 
to the C-terminal moiety of nidogen-1. Its corresponding 
cDNA was inserted into a vector driven by the MCK pro-
moter and used to generate transgenic mice. (B) Muscle 
Lm211 and its homolog Lm111 bind to nidogen-1 (Nd), 
agrin, αDG, and α7β1 integrin. Polymerization results from 
the binding of the LN domains (PD) of the Lmα2 (or α1), 
Lmβ1, and Lmγ1 subunits to form a ternary node at the 
N-termini of each laminin. The α2LN domain is defective 
in the dy2J mouse, greatly reducing self-assembly. αLNNd 
can compete with and replace native nidogen-1, binding to 
the Lmγ1-LEb3 domain locus, to create a new short arm 
capable of binding to the other LN domains. (C) αLNNd 
protein expression was probed by immunoblotting of 
extracts from 3- and 8-week-old triceps (Tr) and tibialis 
anterior (TA) (goat anti–Lmα1-LN Ab). Expression was 
detected in αLNNd-Tg but not WT muscle. (D) Immunos-
tained sections of triceps muscle from 3-week-old WT and 
αLNNd-Tg mice revealed a sarcolemmal BM distribution 
of αLNNd (anti-F2, reacting with Lmα1LN-LEa) similar to 
that of Lmα2 (rat anti-Lmα2). Scale bar: 100 μm.
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0.01 for control muscles (Figure 3J). Other forelimb muscles showed 
similar pathology and improvement in the presence of the transgene.
We also examined the hind limb quadriceps muscle rectus 
femoris (Supplemental Figure 2). The same general improvements 
were observed, with several exceptions. First, the total number of 
myofibers was similar among control, dy2J, and Tg+dy2J muscles 
(Figure 3H). Second, the reduction in the fraction of central nuclei 
was substantial but not as great (~0.22 in dy2J muscle and 0.10 
in Tg+dy2J muscle), and the distribution of myofiber areas was 
greatly improved, but not to the same degree as that observed in 
control muscle. Thus, hind limb muscles were improved by the 
expression of αLNNd, as were forelimb muscles, although these 
improvements did not reach control levels. Some of the differenc-
es observed in the forelimb muscle may be accounted for by the 
confounding effects of the hind limb paralysis.
further increase in the extent of interstitial material that stained 
bright red with Picrosirius red, indicative of the increased collagen 
deposition seen in fibrosis. The presence of the transgene greatly 
improved the H&E- and Picrosirius red–stained morphology, such 
that it closely resembled that of control muscle, with the exception 
of some residual central nuclei. Using morphometry, we quanti-
fied the dystrophic changes and compared them with those in mice 
expressing the transgene. Of the parameters measured, all but the 
number of centralized myonuclei were normalized to control levels 
by expression of the transgene. These included the frequency of dis-
tribution of myofiber areas (Figure 3G), average total cross-sectional 
area (Figure 3G inset), overall myofiber size (Figure 3H), myofiber 
count (Figure 3I), and degree of fibrosis (Picrosirius red fluores-
cence; Figure 3K). The average fraction of myofibers with central 
nuclei was reduced from approximately 0.2 to 0.06 compared with 
Figure 2. Mouse-specific grip strength. Forelimb (A), hind limb (B), and 
combined limb (C) measurements were conducted on control, dy2J, and 
αLNNd plus Tg+dy2J mice between 3 and 11 weeks of age. Values shown 
represent the mean ± SEM of individual averaged mouse sets of grip 
strength determinations divided by mouse mass. The number of mice 
used for each determination is indicated in red. Lowercase red letter 
pairs indicate the statistical significance ranges, which were determined 
by 1-way ANOVA with pairwise Holm-Sidak comparisons (P value ranges 
are indicated in the lower right corner of the top and bottom panels). 
NS, not significant. Dy2J mice showed reduced forelimb grip strength 
by 4 weeks of age. Grip strength was improved to near-control levels 
with the αLNNd transgene and became indistinguishable from that of 
control mice by 6 weeks of age. For hind limbs, the transgene partially 
increased grip strength between 3 and 7 weeks, but not thereafter, 
corresponding to the emergence of hind limb contractures. Note that 
the peripheral nerve defect, which selectively affected the hind limbs, 
was not corrected, because a muscle-specific promoter was used to 
drive αLNNd expression. Combined (all-limb) grip strength was reduced 
in dy2J mice, with substantial improvement (~50%) detected in the 
presence of the transgene.
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Figure 3. Forelimb muscle histology. (A–C) H&E staining of cross sections of the corresponding region of 11-week-old extensor carpi radialis muscle. (D–F) 
Picrosirius red collagen staining of adjacent sections. White arrows indicate examples of central nuclei in magnified insets (original magnification, ×3). The 
morphology of rounded, variable-sized myofibers with increased interfiber collagen–positive staining, characteristic of dystrophic muscle, was improved by 
the transgene to more closely resemble control muscle morphology. Scale bars: 100 μm. (G) Histogram showing the distribution of cross-sectional myofi-
ber areas comparing control, dy2J, and Tg+dy2J mice (n = 5 mice/condition; data represent the average ± SD). Inset graph in G shows the overall myofiber 
cross-sectional area (average ± SEM, n = 5/condition). Histogram plot shows a smaller size distribution for dy2J muscle but a normal distribution and overall 
average for Tg+dy2J muscle. (H) Average (mean ± SD, n = 5 mice/condition) of the sum of myofiber cross-sectional areas. The area reduction in dy2J muscle 
was corrected by the transgene. (I) Number of myofibers per muscle (average ± SD, n = 5/condition). The number of myofibers was reduced in dy2J muscle 
and increased to levels indistinguishable from those of control muscle with the transgene. (J) The fraction of myofibers (average ± SD, n = 5/condition) with 
central nuclei (regeneration marker), elevated in dy2J muscle, was decreased in the presence of the transgene. (K) Picrosirius red fluorescence, a collagen 
stain, was reduced to levels indistinguishable from those in control muscle (average ± SD, n = 5/condition). Individual mouse values are superimposed on the 
average bars in panels G–K. P value determined in G–K by 1-way ANOVA followed by pairwise Holm-Sidak test.
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Laminin in muscle. Sections of 4-week-old triceps from litter-
mate mice were examined by immunostaining to detect Lmα2, 
Lmα4, and Lmγ1 subunits at a stage when fibrosis was still mini-
mal (Figure 4). The images and graphs in Figure 4 show decreased 
levels of Lmα2 and Lmγ1 in dy2J muscle relative to the levels 
detected in control muscle, which is in agreement with previous 
observations (31). The αLNNd transgene increased laminin sub-
units to levels that were not significantly different from those of 
controls (Figure 4, D, H, and L). Lm411 levels, on the other hand, 
were increased in both dy2J and Tg+dy2J muscles relative to the 
levels detected in controls, and this increase was noted in capillar-
ies and, to a lesser degree, in adjacent sarcolemma. Lmα5 (Supple-
mental Figure 3) was similarly localized in the microvasculature 
for all conditions. Sarcolemmal collagen IV was similar for all con-
ditions, as was αDG, while integrin β1 was increased in focal areas 
of dy2J muscle. We found that Lmα4/Lmα2 ratios were elevated 
in peripheral nerves in dy2J and Tg+dy2J mice. We also examined 
muscle ultrastructure. In 4-week-old triceps, the sarcolemma 
appeared similar among control, dy2J, and Tg+dy2J mice (data not 
shown). By 8 weeks, we observed BM attenuations and interrup-
tions and increases in adjacent interstitial collagen fibrils in dy2J 
muscle, whereas Tg+dy2J sarcolemmal BMs and stroma were sim-
ilar to those of controls. The transgene therefore appeared protec-
tive of dy2J muscle ultrastructure.
Laminins were sequentially extracted from 4-week-old fore-
limb skeletal muscle and analyzed as combined total laminins, 
buffer (soluble intracellular and extracellular laminins), and BM 
(matrix) laminins (consisting of collagenase plus EDTA plus SDS 
fractions as described in the Methods section) in sandwich ELI-
SA assays to detect heterotrimeric laminins and by quantitative 
reverse transcriptase PCR (qRT-PCR) to compare mRNA levels 
(Figure 5). The sandwich assays (Figure 5, A–K) showed that total 
Lm211 was reduced and total Lm411 was increased in dy2J muscle 
compared with control muscle, with no significant change between 
dy2J and Tg+dy2J muscle (Figure 5, A–D). In contrast, we found that 
Lm211, Lm411, and Lmβ1γ1 in the matrix fractions were increased 
in Tg+dy2J muscle relative to dy2J muscle (Figure 5, E–J). These 
experiments suggest that the transgene does not affect Lm211 and 
Lm411 total levels but increases their relative contribution to the 
matrix. We then analyzed RNA extracts from forelimb muscle from 
control, dy2J, and Tg+dy2J mice by qRT-PCR (Figure 5, L–R). Tran-
scripts encoding Lmα2 and Lmγ1 (Lama2 and Lamc1, respectively) 
remained constant for all conditions (Figure 5, L and N). In con-
trast, we found that transcript levels of the gene encoding Lmα4 
(Lama4) were doubled in dy2J muscle compared with levels in 
control muscle and remained elevated in the presence of the trans-
gene (Figure 5M). Transcript encoding integrin α7 or β1 increased 
in dy2J muscle and returned to control levels in the presence of the 
transgene, whereas dystroglycan mRNA levels remained constant. 
Fibronectin, an inflammatory marker, was increased in dy2J mus-
cle compared with control and transgene muscle.
We also asked what fraction of muscle laminins is bound to 
αLNNd instead of to endogenous nidogen, the normal laminin part-
nering protein. Combined forelimb muscle extracts from 4-week-
old mice were probed by immunoprecipitation and immunoblotting 
to examine the relationship of αLNNd to nidogen-1, and the laminin 
bound to each (Figure 6). The ratio of αLNNd to nidogen-1 was esti-
mated to be 1:2, with approximately half of the β1γ1-laminins bound 
to αLNNd and the remainder bound to nidogen-1.
Laminin and collagen IV accumulation on C2C12 myotubes, an 
in vitro model of BM assembly. We asked whether the changes in 
laminin observed in the different muscle BMs could be explained 
by the intrinsic assembly properties of polymerizing, nonpolymer-
izing, and polymerization-rescued laminins. To address this ques-
tion, recombinant laminins were allowed to assemble on the lawns 
of fused mouse C2C12 myotubes. While applying BM components 
to myotubes provides imperfect modeling of myomatrix assembly 
in vivo, the approach has proven useful for examining how ini-
tially soluble BM components can assemble on cell surfaces that 
possess relevant α7β1 integrin and αDG receptors, with negligible 
endogenous expression of BM components (32). The culture system 
includes the coassembly of nidogen and collagen IV, like the system 
used to study BM assembly on Schwann cells (14). Lm111 lacking 
either the entire α-short arm or only the LN domain was chosen for 
the analysis, because (a) Lm111 is closely related to neuromuscular 
Lm211, and both proteins polymerize and bind to nidogen, α7β1 
Figure 4. Muscle laminins. (A–L) Immunofluorescence 
microscopy. Frozen sections of 4-week-old forelimb triceps 
brachii from control, dy2J, and Tg+dy2J littermates were 
rinsed, fixed, and immunostained with an Ab specific for 
the Lmα2 (L4b domain, A–D), Lmα4 (E–H), and Lmγ1 (I–L). 
Original magnification, ×20 objective; scale bar: 100 μm. 
(D, H, and L) Graphs of the overall degree of immuno-
fluorescence difference as estimated by segmentation 
(sum of pixel intensities minus background) and divided 
by the traced sum of BM lengths (I/BML) for the above 
Abs. Data represent the average ± SD for 8 to 12 fields per 
condition. P values were determined by 1-way ANOVA with 
Holm-Sidak pairwise comparisons. C, control; D, dy2J; T, 
Tg+dy2J. Reductions in Lmα2 and Lmγ1 subunit levels were 
seen in homozygous dy2J muscle and were increased in 
Tg+dy2J muscle. Lmα4 levels were increased in both dy2J 
and Tg+dy2J muscle.
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integrin, and αDG; (b) Lm111 can fully rescue the severe dystrophy 
and peripheral neuropathy of the Lama2-KO mouse (33, 34); and (c) 
a collection of α1-laminins bearing deletions and point mutations 
that affect specific functions have been generated, characterized, 
and previously used to dissect laminin functions in the laboratory 
(14, 35, 36). In addition, the assembly of WT recombinant Lm211, 
Lm411, and Lm511 was compared with that of Lm111.
Lm111 and nidogen-1 were evaluated at a concentration of 28 
nM, a condition found to approach saturation of accumulation, 
while collagen IV was evaluated at 14 nM, the highest soluble, 
usable concentration (19, 37). We used BM component cell-surface 
accumulation to estimate assembly (14, 15, 32) and observed that 
Lm111 accumulated on myotubes in the absence of other added 
components, while nidogen and collagen IV did not assemble in 
the absence of laminin (Supplemental Figure 4, A–E). Further-
more, nidogen binding to laminin (14, 38) was required for colla-
gen IV accumulation. These findings were qualitatively similar to 
observations made on cultured Schwann cells (14). The fine pattern 
of surface laminin in the myotubes was similar to that observed 
with EHS-Lm111 and thought to represent a precostameric distri-
bution (32). Laminin accumulation approached a maximum value 
at approximately 30 nM, whereas collagen IV achieved a maximum 
value at approximately 3 nM Lm111 (Supplemental Figure 4E).
Lm211 is the principal laminin of the muscle’s sarcolemmal 
BM. When the α2-subunit is absent, the α4-subunit, normally pres-
ent in the muscle capillaries, appears in the sarcolemma (22, 39). In 
order understand muscle isoform assembly, we evaluated Lm211, 
Lm411, and Lm511 (the latter being a microvascular laminin with 
limited sarcolemmal expression) accumulation on myotubes (Sup-
plemental Figure 4, F–M). We found that Lm211 and Lm511, both 
polymerizing laminins with LG domain–mediated adhesion (16), 
accumulated on myotubes at similar levels. However, we detected 
almost no myotube Lm411 accumulation, even when it was coincu-
bated with an equimolar concentration of αLNNd (Supplemental 
Figure 4, G and H), a finding that may be explained by weak recep-
tor binding of Lm411 (12, 23). Comparable collagen levels were 
detected for the polymerizing laminins Lm111 and Lm211, whereas 
Lm411 and Lm411 plus αLNNd did not show accumulation.
We then examined the effect of αLNNd on nonpolymerizing 
recombinant Lm111 and collagen IV (Figure 7). LmαΔLN-L4b 
lacks an α1-short arm (with its critical α1LNd domain) but pos-
sesses LG domains that bind well to αDG and integrin α7β1 (14). 
LmαΔLN-L4b accumulated on myotubes at a 2- to 3-fold reduced 
level compared with WT Lm111. When LmαΔLN-L4b was add-
ed to myotubes with an equimolar concentration of αLNNd, we 
detected accumulation at levels equal to those of WT Lm111. In 
contrast, we observed no alteration of WT Lm111 when it was 
coincubated with αLNNd, indicating that duplication of the αLN 
domain had no significant effect on laminin assembly. We found 
that accumulation of collagen IV was also impaired, but less so, in 
the LmαΔLN-L4b mutant. A mixture of αLNNd and LmαΔLN-L4b 
restored the accumulation of collagen IV to levels slightly below 
those observed with WT Lm111 (Figure 7, D and E). These experi-
ments show that αLNNd is capable of compensating for the loss of 
the LN domains in Lm111 to mediate binding to myotubes.
We evaluated the concentration dependency of laminin 
assembly for WT Lm111 and nonpolymerizing LmαΔLn-L4b and 
LmαΔLN (Supplemental Figure 5, A–F). LmαΔLN, a second mod-
ified laminin that we examined, is similar to dy2J Lm211, in that 
both selectively lack an αLN domain and bind well to αDG and 
integrin α7β1. WT Lm111 accumulation approached a plateau at 
concentrations above 20 nM (Supplemental Figure 5, A and B). 
We found that LmαΔLN-L4b accumulation was below that of WT 
Lm111 at all concentrations examined. αLNNd increased LmαΔLN-
L4b accumulation to levels nearly identical to those of WT Lm111 
(Supplemental Figure 5, C and D). The nonpolymerizing laminin 
(LmαΔLN) that selectively lacks the LN domain also accumulated 
poorly compared with WT laminin (Supplemental Figure 5, E and 
F). αLNNd substantially increased this accumulation as well.
αLNNd-nidogen competition. The degree of αLNNd occupan-
cy on laminins (Figure 6) may in part result from competition 
between transgenic αLNNd and endogenous nidogen-1 for the 
same binding locus in the laminin γ1-short arm, a possibility, giv-
en a report that the nidogen/laminin molar ratio in muscle is 2:1 
(40). We examined this in C2C12 myotubes (Supplemental Figure 
5, G and H) and found that when αLNNd was maintained constant 
and the nidogen-1 concentration increased over that of αLNNd, 
laminin accumulation progressively declined. The limited extent 
of this reduction may be a consequence of a favored assembly for 
those laminins that polymerize.
Discussion
αLNNd is a laminin-binding protein that can restore polymer-
ization activity in laminins with defective α-subunit short arm 
domains. Its C-terminal globular domain binds to the 1 subunit 
of laminins at the nidogen-binding locus in domain LEb3, which 
is located near the point of the short arm trifurcation to provide a 
synthetic short arm with an active α1LN domain at its N-terminal 
tip. The engineered protein also contains binding sites for collagen 
IV and perlecan, retaining the known BM activities of nidogen.
In this study, we evaluated whether αLNNd can restore mus-
cle function and structure in dystrophic dy2J mice by driving 
expression of a transgene coding for the fusion protein using a 
muscle-specific promoter. This analysis revealed that αLNNd 
expression was strongly beneficial to the dystrophic mice, repair-
ing grip strength and muscle histology. The improvement was 
especially evident in forelimb muscles that were largely unaffect-
ed by the accompanying and uncorrected Lmα2-deficient periph-
eral nerve defect. Tg+dy2J forelimb grip strength, reduced in dy2J 
mice, was indistinguishable from that of control mice by 6 weeks 
of age. Complementing forelimb grip strength improvements, 
Tg+dy2J forelimb muscle was essentially indistinguishable from 
that of control forelimb muscle in terms of myofiber architecture, 
size, shape, and numbers, as well as network-like endomysial 
collagen distribution. The only difference we discerned was that 
the fraction of myofibers with central nuclei was not completely 
restored to control levels. We found that the phenotypic benefit 
of the transgene in dy2J muscle was accompanied by an increase 
in total γ1-laminins and Lm211 in sarcolemmal BM as detected 
by immunostaining and biochemical means. We also noted an 
increase in Lm411, a minor laminin that was increased by 2-fold 
in dy2J muscle. The increase, noted at even higher levels in a 
severe laminin-deficient dystrophy (22), was thought to be driv-
en by increased transcription, measured in dy2J muscle as a 2-fold 
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competent short arms and receptor-interactive LG domains, 
assembled to similar degrees on myotubes. In contrast, the com-
pensatory laminin isoform Lm411, which lacks an α-short arm and 
has poor LG-binding interactions, did not assemble on myotubes 
in the presence of αLNNd. This provided evidence that both con-
ditions of LN-mediated polymerization and LG-mediated anchor-
age are required for efficient laminin assembly.
increase in the subunit mRNA. A further increase in Tg+dy2J mus-
cle appeared largely confined to capillary BMs and may not have 
materially contributed to the improved dy2J muscle phenotype.
The Lmα2 subunit is expressed in both muscle endomysium 
and peripheral nerve Schwann cell endoneurium. A reduction of the 
Lmα2 subunit in Schwann cells, as seen in dy2J mice, causes a failure 
of radial sorting and amyelination, with forelimb nerves being less 
affected than hind limb nerves (41). The hind limb gait defect result-
ing from a selective Schwann cell ablation of the LAMC1 gene (P0 
promoter) is similar to that seen in dy2J mice and consists of prom-
inent hind limb weakness, followed by paralysis and permanent 
contractures, with little impairment of the forelimbs (42, 43). Min-
imal involvement of amyelination in forelimb function can further 
be deduced from the complete transgene-driven recovery of nor-
mal forelimb grip strength. Since the MCK promoter only enabled 
αLNNd expression in muscle, dystrophic Lm211 was not altered in 
Tg+dy2J endoneurium (Supplemental Figure 3C), and hind limb grip 
strength was only partially improved in the time frame prior to the 
onset of contractures. It follows that the partial persistence of small 
myofibers in the Tg+dy2J hind limb histology may simply reflect 
neuropathic disuse atrophy. However, it is unclear whether per-
sistent amyelination can also lead to a small degree of muscle fibro-
sis, as noted in the hind limb, or, instead, whether hind limb muscle 
requires a higher level of laminin repair than does forelimb muscle.
We evaluated the assembly of WT and nonpolymerizing 
laminins on cultured myotubes in tissue culture and compared this 
with the changes observed in dystrophic and transgenic/dystrophic 
mice. This in vitro analysis confirmed that BM assembly requires 
laminin assembly on cell surfaces and that the collagen accumula-
tion substantially depends on a nidogen bridge between laminin 
and collagen. Only a relatively small concentration of laminin was 
required to obtain maximal collagen IV accumulation. This rela-
tionship may explain why, in contrast to laminin, major changes 
in collagen IV immunostaining were not noted in control, dy2J, 
and Tg+dy2J muscle. Strikingly, we found that efficient laminin 
cell-surface assembly was dependent on laminin polymerization. 
In the absence of polymerization activity, laminin accumulation 
was reduced by as much as 3-fold over a wide concentration range. 
When αLNNd was added in equimolar amounts to nonpolymeriz-
ing laminin, laminin accumulation increased to levels the same or 
nearly the same as WT polymerizing laminin. We also found that the 
laminin isoforms Lm211 and Lm511, possessing polymerization- 
Figure 5. Muscle extracts. (A–K) Sandwich ELISA determination of laminin content in forelimb muscle. ELISA plates coated with rabbit polyclonal anti-Lmα2  
(A, B, E, and F), anti-Lmα4 (C and D), anti-Lmβ1γ1 (G and H), or anti-nidogen G2-G3 domains (I and J) were incubated with serial dilutions of total combined lysate 
fractions (A–D) or “matrix” (collagenase plus EDTA plus SDS) fractions (E–J) extracted from muscle from four 4-week-old control (+/+ and dy2J/+), dy2J-mutant, 
and αLNNd-Tg dy2J/dy2J mice. Laminins were detected by ELISA after treatment with Lmβ1γ1-specific Ab (A–F, I, and J) or Lmα4-specific Ab (G and H). Plots show 
the relative average laminin absorbance (± SD, n = 4/condition) for Lm211 (total, B), Lm411 (total, D), Lm211 (matrix, F), Lm411 (matrix, H), and total nidogen-bound 
laminins (matrix, J). (K) GAPDH and α-actinin blots for each mouse muscle shown, with the latter used as a myofiber denominator. Lm211 was reduced, while 
Lm411 was increased in dy2J muscle lysates compared with control muscle total lysates, with no significant change in transgenic mouse muscle lysates. However, 
the pooled matrix fractions, after removal of soluble and loosely bound protein, contained significant increases of Lm211 and nidogen-binding laminins in Tg+dy2J 
muscle compared with dy2J muscle. To relate laminin levels to muscle α-actinin, the averaged A450/lysate volume ratios in A, C, E, G, and I were divided by the 
relative α-actinin immunoblot (K) intensities (A/α-act), shown in the corresponding plots in B, D, F, H, and J. (L–R) Changes in relative muscle mRNA by qRT-PCR 
(ΔΔCt) at 4 weeks revealed that Lama2, Lamc1, and dystroglycan levels were not significantly different in WT, dy2J, or Tg+dy2J muscle. Lmα4 (Lama4) levels 
were similarly increased in dy2J and Tg+dy2J muscle (but not increased in Tg+dy2J muscle relative to dy2J muscle alone), while integrins α7 and β1 and fibronectin 
(inflammatory marker) were increased in dy2J muscle and reduced in Tg+dy2J muscle. The presence of αLNNd did not change the Lama4 mRNA levels in WT mice. 
Average and SD plots are shown (n = 4 mice/condition in L–P and R; n = 3 for control and n = 4 for dy2J and Tg+dy2J mice in Q). Graphs also show individual mouse 
values (colored circles) superimposed on bars. Statistical significance was determined by 1-way ANOVA with Holm-Sidak comparisons. Av, average.
Figure 6. αLNNd and nidogen-1 in muscle. (A) Combined extracts (B plus 
C plus E) from 4-week-old forelimb dy2J and Tg+dy2J muscle were immu-
noprecipitated twice with αLNNd-specific Ab (anti-F2, IP #1 and IP #2). 
The αLNNd-depleted supernatants were then immunoprecipitated with 
anti-nidogen G2-G3 (IP #3 and IP #4). Precipitates, following SDS-PAGE 
and membrane transfer, were immunoblotted with anti-Lmβ1γ1 (upper 
cut membrane, dotted cut line shown) and anti-nidogen G2-G3 (lower cut 
membrane). αLNNd was detected only in the Tg+dy2J muscle. (While a small 
amount of nidogen was present in the anti-F2 immunoprecipitates of the 
dy2J control muscle, this band was similarly seen in immunoblots precipitat-
ed with anti-IgY agarose beads alone and deduced to result from nonspecific 
nidogen binding to beads). Following αLNNd depletion, isolated nidogen 
was immunoprecipitated with anti–nidogen G2-G3 Ab. The upper αLNNd 
band was distinguished from the adjacent nidogen band to determine the 
relative amounts in the lysates (IP #1 plus IP #2). To estimate the fraction 
of β1γ1-laminins bound to αLNNd and to nidogen-1, the laminin band inten-
sities were multiplied by the fraction of αLNNd and nidogen-1 in each blot to 
determine the distribution and then summed. (B) Plot (average ± SD,  
n =  4 mice/condition, P = 0.007, by 2-tailed t test) of the calculated fraction 
of αLNNd relative to the total of αLNNd plus nidogen and the fraction of β1γ1 
laminins bound to αLNNd relative to total β1γ1 laminins. Lm, laminins.
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in its ability to restore normal function in dystrophic Lama2-KO 
mice (33, 34), an approach that may also benefit the dy2J phenotype 
if the induced expression of the full-length laminin α-subunit is high 
enough to compete with the defective endogenous Lmα2 subunit for 
heterotrimeric chain assembly. However, application of this ther-
apeutic approach will be difficult to translate to patients, given the 
large size (9.3 kb) of the DNA construct. Whether recombinant pro-
tein injection would be efficacious remains to be established (44). 
Adeno-associated virus (AAV) is one of the most promising of the 
gene delivery systems, as high expression levels can be achieved. 
However, the DNA-coding insert, inclusive of its promoter, is lim-
ited to approximately 5 kb (45). Transgene- and AAV-mediated 
expression has been found to similarly improve the severe laminin- 
deficient dystrophy of the dyW/dyW mouse, likely acting by increas-
ing Lm411 receptor binding (22, 46). The current study suggests that 
AAV expression of αLNNd would be beneficial for the treatment of 
laminin deficiency for those patients with a defective LN domain and 
The polymerization-dependent decrease of laminin accu-
mulation observed in vitro was also observed in dy2J muscle, 
as detected in immunostained tissue and measured in extracts. 
Transgene-driven αLNNd expression acted as an effective 
enabler of laminin accumulation in dystrophic muscle. This 
increase was accompanied by substantial improvements in 
muscle strength and muscle histology. Our evaluation of dy2J 
laminin occupancy by αLNNd suggests that approximately 
half of the nonpolymerizing laminin is bound to endogenous 
nidogen-1, a major BM component of muscle and other tissues. 
This finding is not surprising, given that αLNNd must compete 
with endogenous nidogen-1 for binding to laminins and that 
nidogen-1 is normally in molar excess to laminin. The import-
ant lesson may be that total αLNNd occupancy is not essential 
for a major phenotypic improvement.
A direct approach of restoring laminin expression by germline 
transgene expression of the entire Lmα1 subunit was very effective 
Figure 7. Effect of αLNNd on nonpolymerizing laminin assembly on C2C12 myotubes. (A) Lm111, in which the α1-short arm has been deleted (LmαΔLN-
L4b), binds to αLNNd. (B–E) Lawns of fused C2C12 myotubes were incubated with the indicated WT and polymerization-deficient Lm111 (28 nM) in the 
presence of nidogen-1 (28 nM) and collagen IV (14 nm), without or with αLNNd (28 nM) for 1 hour, followed by washing, fixation, and immunostaining. 
Representative myotube images are shown in B (Lmγ1 immunofluorescence) and D (collagen IV immunofluorescence) (scale bar: 200 μm), with corre-
sponding graphs of the average summed intensities ± SD (n = 7–9 × 10 fields/condition; 1-way ANOVA with pairwise Holm-Sidak comparisons) shown in 
C and E. A substantial decrease of nonpolymerizing LmαΔLN-L4b accumulation compared with WT control was prevented when αLNNd was coincubated 
with LmαΔLN-L4b. In contrast, αLNNd did not alter WT laminin accumulation. Smaller collagen IV differences were detected among polymerizing and 
nonpolymerizing laminins. IF, immunofluorescence; Lm, laminin.
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that, in combination with mini-agrin (mA), this expression might be 
beneficial for all laminin-deficient dystrophies.
In summary, the current study demonstrates that repair of a 
laminin polymerization defect can substantially ameliorate a lami-
nin LN-deficient muscular dystrophy, affecting BM assembly, mus-
cle histology, and muscle strength. It also illustrates the value of an 
in vitro model for BM assembly to predict outcomes in vivo. The key 
interactions identified in this study are that the laminin must polym-
erize, must bind to its receptors, and must bind to nidogen to form an 
effective bridge to collagen IV. These interactions create a stable BM 
that supports muscle function (Figure 8). If a laminin polymerization 
domain is lost, Lm211 is rarified in the BM, thereby destabilizing it. 
This deficit can be repaired with αLNNd, a laminin-binding protein 
modified to replace the defective domain and interact with the defec-
tive laminin to assemble a stable BM. Finally, we believe our study 
sets the stage for the development of therapeutic approaches utilizing 
engineered laminin-binding proteins that provide missing functions.
Methods
DNA constructs. Expression vectors for the mouse laminin α1, human 
β1, and human γ1-subunits; for deletions of α1LN, α1LN-L4b, α1LG1-
5, β1LN, and γ1LN for αLNNd; for mouse nidogen-1; and for chick 
non-neural mA were generated as previously described (14, 15). To 
generate the αLNNd expression vector for the transgenic mouse line, 
the LNNd ORF from the pcDNA3.1 Zeo plasmid was digested with 
XbaI and XhoI and inserted into the muscle-specific expression vec-
tor BS mck+polyA (22), which contains the muscle-specific creatine 
kinase promoter MCK (Figure 1A). The BS mck+polyA vector was also 
digested with the same enzymes to insert the αLNNd ORF into the 
multiple cloning sites of the expression vector. DNA was linearized 
with restriction endonuclease PvuI for DNA injections.
A cDNA construct to express mouse laminin-α4 with an N-terminal 
FLAG tag was prepared with a KpnI and NotI digest of α4 Blunt II TOPO 
(GE Dharmacon; EMM1002-97544805) and ligation into pcDNA3.1 
puro. An N-FLAG tag was added into an NheI-BstEII site with overlap-
ping PCR (1 forward, 5′-TGGCTGACCGCCCAACGAC-3′; 1 reverse, 
5′-CAGGTGGGGCAAGGGACAGG-3′; 2 forward, 5′-GACGACGAT-
GACAAGGCGTCAGGGGACGGCAAT-3′; 2 reverse, 5′-ATTTGC-
CGTCCCCTGACGCCTGTCATCGTCGTC-3′). Mouse α5 (a gift of Jeff 
Miner, Washington University School of Medicine, St. Louis, MO, USA) 
was inserted into pcDNA3.1 puro with EcoRI as described previously 
(47). A FLAG tag sequence was added to the C-terminus with overlap-
ping PCR (1 forward, 5′-GCCTGTATGTGGATGACCAGCTAC-3′; 1 
reverse, 5′-CGACGATGCAGTTCAATGGTCG-3′; 2 forward, 5′-CAT-
GACTACAAGGACGACGATGACAAG-3′; 2 reverse, 5′-GTCCTTG-
TAGTCATGCCAAAGTAGCGG-3′) at an NsiI site. The human γ1 ORF 
was moved from pRC-Cmv2 to pcDNA3.1neo with BamHI.
Recombinant and native laminins and other proteins. HEK293 cell 
lines stably expressing recombinant Lm111 heterotrimers (WT and 
deletion modified) and αLNNd were purified by HA-affinity chroma-
tography as described previously in detail (36). Lm211 from cells grown 
in the presence of the furin inhibitor 1 (5 μM in medium; Calbiochem; 
catalog 344930) to reduce LG domain cleavage (48) was purified by 
heparin affinity chromatography (heparin-agarose column), keeping 
the fraction that eluted between 250 and 500 mM NaCl in 50 mM 
Tris-HCl, pH 7.4. HEK293 cells stably expressing Lm411 or Lm511 with 
an Lmα4 N-terminal FLAG tag or an Lmα5 C-terminal FLAG tag were 
Figure 8. Model of laminin assembly in normal, dystrophic, and αLN-
Nd-repaired muscle. (A) Normally, Lm211 adhesion (LG domain–mediated) 
to sarcolemmal αDG and α7β1 integrin is coordinated with its polymer-
ization. Assuming similarity with Schwann cell BM assembly, sulfated 
glycolipids (SGLs) might contribute to laminin adhesion in muscle as well. 
The heparan sulfate chains of perlecan and muscle agrin are thought to 
mediate bonds between laminin and nidogen and the collagen network. 
(B) In the dy2J (and some cases of human Lmα2) dystrophic state, Lm211 
can still adhere to the sarcolemma but has lost its ability to polymerize. 
Findings of this study suggest that secreted laminin accumulates at 
reduced levels in the BM because of the loss of binding cooperativity with 
other architectural and receptor components. (C) In the Tg+dy2J mouse, 
αLNNd binds to the defective nonpolymerizing Lmα2, thereby enabling 
self-assembly. Endogenous nidogen-1 competes with αLNNd for binding to 
laminins, creating a mixture of polymerized and nonpolymerized laminins, 
the former favored for assembly into stable BM. While Lm411 polymer-
ization is also enabled by αLNNd, the small increase is largely confined to 
capillaries adjacent to the myofibers in dy2J muscle.
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ic DNA per 20-μl reaction according to the Jumpstart Taq instructions 
(Sigma-Aldrich; catalog P2893). PCRs were performed for dy2J mice 
with primers at final concentrations of 5 pmol/μl using dy2J forward, 
5′-TCCTGCTGTCCtGAATCTTG-3′ and dy2J reverse, 5′-CATTCTGT-
GCCAGGGAGTC-3′ to generate a 300-bp product under the following 
thermocycler conditions: 94°C for 5 minutes and 35 cycles of 94°C for 
30 seconds; 52°C for 30 seconds; 72°C for 1 minute; and ending with 
72°C for 3 minutes. Following amplification, the PCR products were 
digested for 2 hours at 37°C with Fermentas Fast Digest NdeI Enzyme 
to yield either a 300-bp, 200-bp plus 100-bp, or 100-bp banding pat-
tern when run on a 1% agarose gel to indicate the WT, dy2J/+, or dy2J/dy2J 
genotypes, respectively (51). For transgenic mice, the BS-MCK/αLNNd 
expression construct was injected into C57Bl/6J mouse oocytes at the 
Transgenic Mouse Core Facility of the University of Basel. Transgen-
ic lines (C57Bl/6J) were identified by PCR and Southern blot analysis. 
Of the 2 αLNNd-transgenic mouse lines generated, the line with high-
er detectable protein levels was used for the study. These mice were 
bred with dy2J/+ mice to generate dystrophic animals (dy2J/dy2J with or 
without αLNNd) and controls (+/+ and dy2J/+ with or without αLNNd). 
No histological defects, gait abnormalities, or weakness was detected 
among the control genotypes.
Tissue harvesting and mouse muscle histology. Forelimbs and hind 
limbs were dissected from euthanized mice at 3 to 4 and 11 weeks of 
age. For paraffin embedding, forelimbs and hind limbs were fixed in 
10% buffered formalin overnight (Sigma-Aldrich; catalog SF93-4) 
after removal of skin. Specimens were incubated overnight at RT with 
an acidic decalcification solution (Cal-Ex CS510-1D; Thermo Fisher 
Scientific) and washed in running tap water for several hours, refixed 
in 10% formalin overnight, rinsed, cross sectioned, and maintained in 
70% ethanol for tissue processing. Tissues were embedded, sectioned 
at a thickness of 5 μm, and stained with H&E at the Histopathology 
Core (The Rutgers Cancer Institute of New Jersey, New Brunswick, 
New Jersey, USA). Slide-mounted, unstained sections cut adjacent 
to those stained with H&E were deparaffinized and stained with 
Picrosirius red in picric acid to detect collagens (Sirius Red Stain Kit, 
NovaUltra, IW-3012; IHC World) according to the manufacturer’s 
instructions. Composite images of extensor carpi radialis and rectus 
femoris were generated from partially overlapping images. Collagen 
levels were estimated by determining the red fluorescence of entire 
muscle cross sections from different mice stained in parallel (52). A 
segmentation range was defined and applied to all mice evaluated to 
capture the fibrosis accumulation within the given muscle using IPLab 
3.7 software (Scanalytics Inc.). That segmentation value (sum value 
in pixels) was divided by the area (in pixels) of the muscle group to 
achieve the percentage of fibrosis for the rectus femoris muscle for a 
given mouse. For frozen sections, unfixed limbs were cross sectioned, 
mounted, and oriented in OCT and rapidly frozen in liquid nitrogen. 
For electron microscopic analysis, skeletal muscle was fixed in 0.5% 
gluteraldehyde and 0.2% tannic acid in PBS for 1 hour, washed with 
0.1 M sodium cacodylate buffer, transferred to modified Karnovsky’s 
fixative, post-fixed in 1% osmium tetroxide for 1 hour, and prepared 
and imaged as previously described (36).
Morphometry. Myofiber cross-sectional areas and perimeter lengths 
were measured from bright-field images of paraffin-embedded, stained 
sections and immunostained frozen sections. Images (×20 objective) 
from paraffin-embedded sections were recorded with a Nikon Eclipse 
50i microscope fitted with a Diagnostic model 18.2 color mosaic camera 
prepared using FLAG-M2 Ab affinity chromatography (14). Recombi-
nant mouse nidogen-1 was purified from conditioned medium using 
HisPur-cobalt chelating chromatography (Thermo Fisher Scientific; 
catalog 89965) and detected with a rabbit polyclonal Ab as previous-
ly described (15) or with anti-entactin (Chemicon; catalog MAB1946). 
Type IV collagen was extracted from lathyritic mouse Engelbreth-
Holm-Swarm (EHS) tumor and purified as previously described (37).
Protein determinations. Molar laminin concentrations were deter-
mined by densitometry of Coomassie blue–stained acrylamide gels 
compared with an EHS-laminin (710-kDa protein mass) standard (19), 
corrected for changes in the calculated mass (LmΔαLN-L4b, 558 kDa), 
Lm-411 (513 kDa), Lm-511 (784 kDa), and Lm-211 (718 kDa) as previ-
ously described (14, 15). Absorbance at 280 nm was used to measure 
the concentration of αLNNd (157 kDa).
Culturing, immunostaining, and analysis of BM assembly in C2C12 
myotubes. Mouse C2C12 myoblasts (ATCC CRL-1772) were maintained 
and differentiated into myotubes on using a previously described 
method (49). Myoblasts were maintained in DMEM, 10% FCS, and 
penicillin-streptomycin. Cells between passages 6 and 7 were plated 
onto 24-well dishes at 250,000 cells per well and incubated at 37°C 
overnight. The following day, the media were changed to DMEM, 5% 
horse serum (Gibco, Thermo Fisher Scientific), and 1% penicillin- 
streptomycin, and cells were allowed to fuse for 4 to 5 days at 37°C. 
Myotube cultures were washed 3 times with PBS, followed by fixation 
in 3.5% paraformaldehyde in PBS for 30 minutes at room temperature 
(RT). Cultures were blocked overnight at 4°C with 5% goat serum and 
0.5% BSA in PBS. Myotube lawns were stained with primary polyclon-
al and monoclonal Abs specific for laminin subunits, laminin domains, 
nidogen-1, collagen IV, αLNNd, αDG, and integrin-β1 (see Supple-
mental Table 1). Detection of bound primary Abs was accomplished 
with Alexa Fluor 488 and 647 goat anti-rabbit, anti-chicken, and anti-
mouse IgG secondary Abs (Molecular Probes) at 1:200 and FITC- 
conjugated donkey anti-mouse IgM at 1:100 (Jackson ImmunoResearch) 
with nuclear counterstaining with 4′,6-diamidino-2-phenylindole 
(50). Myofiber cultures were viewed by indirect immunofluorescence 
using an inverted microscope (IX70; Olympus) fitted with an IXF-
LA fluorescence attachment and a MicroMax 5-mHz CCD camera 
(Princeton Instruments) controlled by IP Lab 3.7 (Scanalytics). Digital 
images were recorded (5–12 fields, each 1,300 × 1,030 pixels) using 
a ×10 objective microscope objective, with the same exposure time 
for a given primary and secondary Ab set when comparisons were to 
be made. Fluorescence levels were estimated from the digital imag-
es with ImageJ software (NIH), with calculations performed in Mic-
rosoft Excel. A protocol previously described for the measurement 
of laminin on Schwann cells (14) was modified, such that the average 
background/pixel was determined from the fields of untreated myo-
tube lawns by automatic mean-threshold segmentation. The overall 
background was calculated as the background/pixel multiplied by the 
total area of myotube lawn occupying the field and subtracted from 
the sample fluorescence. Data are expressed as the mean ± SD of nor-
malized summed intensities in SigmaPlot 12.5 (Systat Software).
Mice. Dy2J/+ mice (on a C57BL/6J background) were purchased 
from The Jackson Laboratory and used for breeding. For genotyping, 
genomic DNA was purified from mouse tail clippings obtained at the 
time of weaning in 0.1 M NaOH buffer and boiled at 100°C in PCR tubes 
for 15 minutes. Samples were cooled, vortexed, and diluted into 40 mM 
Tris buffer, pH 8.0. Genotyping PCRs were performed with 1 μl genom-
Downloaded from http://www.jci.org on November 15, 2017.   https://doi.org/10.1172/JCI90854
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
1 0 8 7jci.org   Volume 127   Number 3   March 2017
laminins and free extracellular laminins. Bacterial collagenase, which 
disrupts collagen bonds that retain laminins within the BM, was used to 
release laminins (collagenase fraction, C) from matrix in a manner pre-
viously observed with EHS matrix, placenta, and muscle, (18, 20, 25). 
EDTA, a chelating agent that inhibits laminin polymerization, integrin 
binding, and dystroglycan binding, was used to extract laminin, now 
released from its collagen bonds from matrix (EDTA fraction, E). SDS, 
which breaks nearly all noncovalent bonds, was then used to extract 
residual laminin (SDS fraction, S) that might be more tightly embedded 
in the BM matrix. These 3 sequential extractions (C plus E plus S) were 
combined to form the BM matrix fraction after removal of the soluble/
intracellular laminins released by buffer. Mouse skeletal muscle frag-
ments of equal mass were homogenized (Polytron) in 2 ml of ice-cold 
TBS-50 (50 mM Tris, 90 mM NaCl, pH 7.4) with protease inhibitors 
(Sigma-Aldrich; catalog P8340), then incubated on ice for 30 minutes 
with 1% NP40. Homogenates were transferred to 2-ml Eppendorf 
tubes and centrifuged (15,800 g, 20 min, 4°C). The supernatants (buffer 
fraction) were saved, and the pellets were suspended in a collagenase 
solution (0.2 μg/ml bacterial collagenase [CLSPA; Worthington Bio-
chemical] in TBS-50, 4 mM calcium chloride, and protease inhibitors), 
incubated at 37°C for 2 hours with frequent agitation, and centrifuged 
for 20 minutes with the supernatant saved (collagenase fraction). Pel-
lets were then suspended in ice-cold EDTA buffer (20 mM EDTA in 
TBS-50 and protease inhibitors), rocked overnight at 4°C, centrifuged 
(20 min, 4°C), and the supernatants saved (EDTA fraction). The final 
pellet residue was then extracted with Laemmli SDS–solubilizing buffer 
and the supernatant (SDS fraction) saved after centrifugation. Aliquots 
of sequential extracts for each step were analyzed in Western immuno-
blots with GADPH as a loading control and α-actinin as a myofiber con-
trol. Each fractional volume was recorded for later calculations.
ELISA sandwich assay to compare laminins in muscle extracts. Ninety- 
six-well high protein–binding Costar plates were coated (1–2 μg/ml) 
with rabbit polyclonal anti-Lmα2 (2 μg/ml), goat anti-Lmα4 (1 μg/ml), 
or chicken anti-Lmβ1γ1 (1 μg/ml). The wells were then washed and 
blocked with blocking buffer (PBS, 1% BSA, 0.06% Triton X-100). Two-
fold serial dilutions of muscle-extracted proteins were prepared in PBS 
containing 1% BSA and 1% NP40 and applied (0.1 ml) to the Ab-coated 
wells. After incubation for 2 hours at RT, unbound protein was removed 
and the wells washed, and then the wells were incubated with either 
chicken anti-Lmβ1γ1 (1 μg/ml in each well) to detect Lm211 or Lm411, 
or (for matrix to increase sensitivity) goat anti-Lmα4 on the laminins 
bound to chicken anti-Lmβ1γ1. For detection of total β1γ1-laminins, 
wells were coated with rabbit anti-nidogen G2-G3 domains (common 
to nidogen and αLNNd) and detected with chicken anti-Lmβ1γ1. After 
washing, wells were incubated with anti-chicken IgY or anti-goat IgG 
coupled to HRP (1:5,000), washed again, and then incubated with TMB 
(3,3′,5,5′-tetramethylbenzidine) color reagent for 3 minutes. Absorbance 
was measured at A450 following the addition of sulfuric acid to halt fur-
ther color development. The use of serial dilutions for unknowns rather 
than same-dilution replicates allowed for determination of whether the 
unknowns fell into the sensitive, near-linear range of the assay. Averages 
were determined for the first 4 dilutions (ratio of A450/lysate volumes) 
and divided by the corresponding mean control values. The normalized 
values for 4 different mice per condition were then averaged and plot-
ted. These values were divided by the α-actinin levels for each mouse to 
correct for differences in myofiber content (determined as averaged and 
normalized intensity levels from 3 repeat immunoblots).
under the control of SPOT software (version 4.6.4.5; Diagnostic Instru-
ments, Inc). Composite images of whole muscle in cross sections were 
assembled in Adobe Photoshop CS6 from overlapping recorded imag-
es. Individual myofiber perimeters of a given muscle were traced on 
a Wacom Cintiq 22HD screen in ImageJ, with conversion to myofiber 
areas. The fraction of myofibers with central nuclei in the muscle was 
used to estimate the degree of myofiber regeneration.
Abs. Abs against the Lmα1 domains of αLNNd, laminin subunits 
α2, α4, α5, β1/1, and γ1, nidogen-1, nidogen domains G2-G3 common to 
αLNNd and nidogen-1, collagen IV, αDG, and integrin β1 are described 
in Supplemental Table 1. Generally, rabbit and chicken polyclonal anti-
sera were affinity purified on their respective ligands by affinity chro-
matography and cross absorption. Columns of 3 to 4 ml of sepharose 4B 
coupled to ligands were prepared using cyanogen bromide-activated 
beads at 1 to 2 mg/ml ligand/ml beads. Loaded samples were eluted 
with 0.1 M acetic acid, pH adjusted to neutrality, and dialyzed into PBS. 
For cross absorption, the Ab was passed through the column in PBS 
with retention of the unbound fraction. Cross absorption was repeat-
ed until adequate specificity could be demonstrated by ELISA and 
Western immunoblotting (protein in muscle lysates and recombinant 
Lm111, Lm211, Lm411, and Lm511).
Tissue preparation, Ab staining, and microscopy. Skeletal muscles 
were embedded in OCT (Tissue-Tek), flash frozen in liquid nitrogen, 
and stored at –80°C. For sectioning, frozen blocks were first allowed to 
equilibrate to –20°C overnight. Five-micron-thick sections were cut with 
a cryostat (Leica CM 1850) at –20°C and adhered to positively charged 
slides (Thermo Fisher Scientific). Sections were then washed for 5 min-
utes in TBS-50 (or 30 minutes in TBS-50 containing 0.1% NP40 for 
detection of αDG and integrin), followed by fixation in 3.2% parafor-
maldehyde in PBS for 15 minutes at RT. Slides were washed in PBS and 
blocked in 5% goat serum overnight at 4°C. Primary Abs were added the 
following day for 1 to 3 hours at RT and washed 3 times in PBS for 10 min-
utes. Secondary Abs conjugated with fluorescent probes were added for 1 
hour at RT, followed by 30 minutes of 3 PBS washes of 10 minutes each. 
Slides were mounted with coverslips in 6% DABCO (1,4-diazabicyclo 
[2.2.2]octane) in glycerol. Detection of bound primary Abs in fixed, 
frozen sections was accomplished with Alexa Fluor 488 and 647 goat 
anti-rabbit, chicken, and mouse IgG secondary Abs (Molecular Probes) 
at 1:200. Tissue sections were stained simultaneously and Ab titers were 
measured to ensure linear detection of BM components. Regions of mus-
cle were matched between genotypes, and the same exposure times and 
normalizations were applied to all images being compared.
In order to estimate and compare the immunofluorescent inten-
sities for different laminin subunits, multiple near-adjacent ×20 fields 
of cross sections from triceps brachii muscle were recorded and sub-
jected to image segmentation analysis in ImageJ. A mean threshold 
signal value was determined to correspond to the BM zone of the 
image, followed by collection of area and intensity density (sum) val-
ues. A mean background/pixel value for the non-BM zones was also 
determined by the same method, multiplied by the number of BM pix-
els, and subtracted from the BM summed values. The average and SD 
were then calculated. BM lengths were then determined and summed 
for each image by tracing the BMs with a stylus on a Wacom tablet in 
ImageJ. The summed intensities were divided by the BM lengths, with 
calculation of the average and SD of 8 to 12 images per condition.
Extraction and analysis of laminins from muscle. Neutral salt buffer 
containing NP40 (buffer fraction, B) was used to extract intracellular 
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SigmaPlot 12.5 (Systat Software) or Microsoft Excel. Averages and SEM 
were determined from the mean values of consecutive sets of determi-
nations (e.g., grip strength) from different mice and from the mean val-
ues of myofiber cross-sectional areas from different mice. Three or more 
conditions were compared by one-way ANOVA followed by Holm-Sidak 
pairwise analysis in SigmaPlot, while two conditions were evaluated by a 
two-tailed t test using Microsoft Excel. A difference was considered sig-
nificant for P values of 0.05 or less and trended toward significance for P 
values of greater than 0.05 but less than or equal to 0.10.
Study approval. The mouse protocol (I12-074) for the study was 
approved by the IACUC committee of Rutgers University and Rob-
ert Wood Johnson Medical School. The biosafety protocol (IBC no. 
13-574) for the study was approved by the Institutional Biosafety 
Committee of Rutgers University.
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Immunoprecipitation and immunoblot analysis. Equal fractions 
of combined lysates were pre-cleared with either protein-A agarose 
beads (Sigma-Aldrich) for 30 minutes (for rabbit Ab immunoprecip-
itations) or goat anti-chicken IgY agarose beads (GeneScript) for 30 
minutes (for chicken Ab immunoprecipitations). The lysates were then 
immunoprecipitated with Abs against either αLNNd (chicken anti-F2, 
5 μg/ml) or rabbit anti-nidogen (G2-G3 domains, 5 μg/ml). Protein 
A agarose beads (for Lmβ1, γ1-, and α2-subunits) or anti-chicken– 
conjugated agarose beads (for αLNNd) were added and incubated for 
1 hour with gentle agitation. The beads were removed by centrifuga-
tion (10 s) and the supernatants collected. Beads were then washed 
3 times with cold IP-wash buffer (50 mM Tris, 90 mM NaCl, 1 mM 
EDTA, 0.06% Triton X-100). Laemmli buffer containing mercap-
toethanol was added to the pellets. After boiling for 5 minutes, super-
natant aliquots were loaded onto a 7.5% SDS-PAGE reducing gel and 
electrophoresed (80 min, 120 volts). Gel-embedded proteins were 
transferred onto PVDF membranes in cold transfer buffer (25 mM Tris 
base, 190 mM glycine, 0.1% SDS, 20% methanol, pH 8.3) at 100 volts 
for 1 hour. Membranes were blocked overnight in 5% milk protein (50 
mM Tris, 150 mM NaCl, 0.2% Tween-20). Primary Ab against either 
laminin-β1/γ1 (1 μg/ml) or nidogen (1 μg/ml) was added to Western 
Ab buffer (50 mM Tris, 150 mM NaCl, 1% BSA, 0.2% Tween-20) for 3 
hours at RT, followed by three 10-minute washes with Western wash 
buffer (50 mM Tris, 150 mM NaCl, 0.2% Tween-20). Secondary Ab 
(goat anti-rabbit horse-radish peroxidase conjugated) was added at 
1:3,000 to Western Ab buffer for 1 hour at RT, with gentle agitation. 
Membranes were washed 3 times (10 min each) and exposed simulta-
neously with equal volumes of West Femto Kit components (Enhancer 
Solution plus Peroxide Buffer; Thermo Fisher Scientific) on the Bio-
Rad Gel-Dock System and evaluated by Quantity One software (Bio-
Rad). Relative intensities of Lm-β1/γ1 bands were determined using 
GelAnalyzer software (2010a; Lazar Software).
qRT-PCR analysis. RNA was isolated and stabilized from tissues 
with reagents provided by an RNeasy Plus Mini Kit (QIAGEN). qRT-PCR 
was performed to quantify laminins, integrins, and dystroglycan, and 
fibronectin relative to the housekeeping GAPDH gene using a StepOne-
Plus System (Applied Biosystem) as described previously (53).
Grip strength measurements. Grip strength was measured with a 
mouse Grip Strength Meter (Columbus Instruments) according to the 
manufacturer’s instructions (User Manual 0167-007). Forelimb mea-
surements were performed with the wire triangle attachment (pulling the 
mouse rearward by the tail), while all-limb and hind limb measurements 
were performed with the angled grid attachment, pulling the mouse 
towards the meter by the tail after engagement of all limbs, or pulling the 
mouse by the tail by only the hind limbs (forelimbs positioned above the 
mesh by holding the mouse by the scruff of the neck). The recommend-
ed 5 consecutive measurements per mouse protocol was increased to 10, 
with averaging of the 6 (rather than 3) highest values. Data are expressed 
as grams of peak force divided by the mouse’s weight.
Statistics. Averages and SD were calculated from measured values 
obtained from 3 or more images, and morphometric measurements of 
perimeters and areas were performed using the statistical package in 
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